Eicosatrienoic acid (20:3 n-9) inhibits the expression of E-cadherin and desmoglein in human squamous cell carcinoma in vitro

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 59, Issue 6, 1998, Pages 371-377

  Eynard, A R ^a   Jiang, W G ^b   Mansel, R E ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ANTIMETASTATIC AGENT; CELL ADHESION MOLECULE; DESMOGLEIN; ESSENTIAL FATTY ACID; ICOSATRIENOIC ACID; MATRIGEL; UVOMORULIN;

AGED; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; ESSENTIAL FATTY ACID DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0032463636     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90098-9     Document Type: Article

References (47)

1. 1. Horrobin D. F. Nutritional and medical importance of gamma-linolenic acid. Prog Lip Res 1992; 31: 163-194.
2. 2. Mc Clinton S., Moffat L. E. F., Horrobin D. F., Manku M. S. Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer 1991; 63: 314-316.
3. 3. Das U. N., Prasad V. V. S. K., Reddy D. R. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 1995; 94: 147-155.
4. 4. Jiang W. G., Hiscox S., Hallett M. B., Horrobin D. F., Mansel R. E., Puntis M. C. A. Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid. Cancer Res 1995a; 55: 5043-5048.
5. 5. Silva R. A., Muñoz S. E., Guzman C. A., Eynard A. R. Effects of dietary n3 n6 and n9 PUFA's on benz(a)pyrene-induced forestomach tumorigenesis in C57BL6J mice. Prostaglandins Leukot Essent Fatty Acids 1995; 53: 273-277.
6. 6. Lockniskar M., Belury M. A., Cumberland A. G., Patrick K. E., Fischer S. M. The effects of dietary lipids on skin tumor promotion by benzoyl peroxide: comparison of fish coconut and corn oil. Carcinogenesis 1991; 12: 1023-1028.
7. 7. Lands W. E. M. Biochemistry and physiology of n-3 fatty acids. FASEB J 1992; 8: 2530-2536.
8. 8. Davis-Bruno K. L., Halushka P. V. Molecular pharmacology and therapeutic potential af thromboxane A2 receptor. Adv Drug Research 1994; 25: 173-202.
9. 9. Jiang W. G., Hiscox S., Hallett M. B., Horrobin D. F., Scott C., Puntis M. C. A. Inhibition of invasion and motility of human colon cancer cells by gamma linolenic acid. Br J Cancer 1995; 71: 744-752.
10. 10. Jiang W. G., Bryce R. P., Mansel R. E. Gamma linolenic acid regulates gap junction communication in endothelial cells and their interaction with tumour cells. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 307-316.
11. 11. Jiang W. G., Bryce R. P., Horrobin D F. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 1998; 27: 179-209.
12. 12. Sinclair H. M. Deficiency of essential fatty acids and atherosclerosis etc. Lancet 1956; 1: 381-383.
13. 13. Nyrop J. E. Hardened fats and lung cancer. Lancet 1954; 2: 1288.
14. 14. Holman R. T., Adams C. E., Nelson R. A. et al. Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J Nutr 1995; 125: 901-907.
15. 15. Okazaki N., Araki E. Eicosatrienoic acid omega-9 in human hepatoma transplanted into athymic nude mice. Oncology 1978; 35: 153-154.
16. 16. Tocher D. R., Dick J. R., Sargent J. R. Occurrence of 22:3 n-9 and 22 :4 n-9 in the lipids of the topminnow (Poeciliopsiss lucida) hepatic tumor cell line PLHC-1. Lipids 1995; 30: 555-565.
17. 17. Cabre E., Gassull M. A. Polyunsaturated fatty acid deficiency in liver diseases. Pathophysiological and clinical significance. Nutrition 1996; 12: 542-548.
18. 18. Holman R. T. The ratio of trienoic: tetraenoic in tissue lipids as measure of essential fatty acids requirement. J Nutr 1960; 70: 405-410.
19. 19. Aaes-Jorgensen E. Essential fatty acids. Physiol Rev 1961; 41: 1-51.
20. 20. Holman R. T., Mohrhauer H. A hypothesis involving competitive inhibition in the metabolism of polyunsaturated fatty acids. Acta Chem Scand 1963; 17: 584-590.
21. 21. Booyens J., Vandermerwe C. F. Margarines and coronary-artery disease. Med Hypotheses 1992; 37: 241-244.
22. 22. Boltonsmith C., Woodard M., Fenton S., Mc Cluskey M. K., Brown C. A. Trans-fatty acids in the Scottish diet. An assessment using a semiquantitative food frequency questionnaire. Br J Nutr 1995; 74: 661-670.
23. 23. Ratnayake W. M. N., Chen Z. Y. Trans n-3 and n-6 fatty acids in canadian human milk. Lipid 1996; 31: S279-S282.
24. 24. Mead J. F. The essential fatty acids: past, present, future. Prog Lip Res 1981; 20: 1-6.
25. 25. Eynard A. R. Role of dietary polyunsaturated fatty acids (PUFA) on tumorigenesis. Cancer J 1996; 9: 142-144.
26. 26. Eynard A. R., Manzur T., Moyano A., Quiroga P.L., Muñoz S. E., Silva R. A. Dietary deficiency or enrichment on essential fatty acids modulates tumorigenesis on the whole body cobalt 60-irradiated mice. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 239-244.
27. 27. Eynard A. R. Does chronic essential fatty acid deficiency (EFAD) constitute a protumorigenic condition? Med Hypotheses 1997; 4855-62.
28. 28. Jiang W. G. In vitro models of cancer invasion and metastasis: recent developments. Eur J Surg Oncol 1994; 20: 493-499.
29. 29. Jiang W. G., Singhrao S. K., Hiscox S., Hallett M. B., Bryce P. B., Horrobin D. F., Puntis M. C. A., Mansel R. E. Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids. Clin Exp Metast 1997; 15: 593-602.
30. 30. Burr G. O., Burr M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 1929; 82: 345-367.
31. 31. Sinclair H. M. History of essential fatty acids. In: Omega-6 Essential Fatty Acids Pathophysiology and Roles in Clinical Medicine. D. F. Horrobin (Ed) Wiley Liss 1990; 1-20.
32. 32. Elías P. M. The essential fatty acid deficient rodent: evidence for a direct role for intercellular lipid in barrier function. H. I. Maibach, N. J. Lowe (Eds). In: Models in Dermatology vol. 1 Basel Karger 1985; 272-285.
33. 33. Ziboh V. A., Miller C. C. Essential fatty acids. Significance in cutaneous biology. Annu Rev Nutr 1990; 10: 433-450.
34. 34. Snipes R. L. The effect of essential fatty acid deficiency on the ultrastructure and functional capacity of the jejunal epithelium. Lab Invest 1968; 18: 179-189.
35. 35. Kramar J., Levine V. E. Influence of fats and fatty acids on capillaries. J Nutr 1953; 50: 149-60.
36. 36. Kyriakides E. C., Beeler D. A., Edmonds R. H., Balint J. A. Alterations in phosphatidylcholine species and their reversal in pulmonary surfactant during essential fatty acid deficiency. Biochim Biophys Acta 1976; 431: 339-407.
37. 2+. Exp Cell Res 1995c; 220: 424-433.
38. 38. Menton D. N. The effects of essential fatty acid deficiency on the skin of the mouse. Amer J Anat 1968; 122: 337-356.
39. 39. Lowe N. J., De Quoy P. R. Linoleic acid effects on epidermal DNA synthesis and cutaneous prostaglandin levels in essential fatty acid deficiency. J Invest Dermatol 1978; 70: 200-203.
40. 40. Mc Cullough L. L., Schreiber S. H., Ziboh V. A. Cell proliferation kinetics of epidermis in the essential fatty acid deficient rat. J Invest Dermatol 1978; 70: 318-320.
41. 41. Hansen A. E., Holmes S. G., Wiese H. F. Fat in the diet in relation to nutrition of the dog. IV. Histologic features of the skin from animals fed diets with and without fat. Texas Rep Biol Med 1951; 9: 491-515.
42. 42. Hansen A., Haggard M. E , Bolsche A. N., Adam D. J. D., Wiese H. F. Essential fatty acid in infant nutrition. III. Clinical manifestations of linoleic acid deficiency. J Nutr 1958; 66: 565-576.
43. 43. Eynard A. R., Cejas V., Silva R., Quiroga P., Muñoz S. E. Histopathology of the essential fatty acid deficient mice. Nutrition 1992; 8: 37-40.
44. 44. Eynard A. R., Monis B., Kalinec F., Leguizamón R. O. Increased proliferation of the epithelium of the proximal alimentary tract of EFA-deficient rats. A light and electron microscopy study. Exp Mol Pathol 1982; 36: 135-143.
45. 45. Birchmeier W., Beherens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994; 1198: 11-26.
46. 46. Fischer S. M., Leyton J., Lee L. M., Locniskar M., Belury M. A., Maldve R. E., Slaga T. J., Bechtel D. H. Differential effects of dietary linoleic acid on mouse skin-tumor promotion and mammary carcinogenesis. Cancer Res 1992; 52: 2049-2054.
47. 47. Jiang W. G., Eynard A. R., Mansel R. E. The pathology of essential fatty acid (EFA) deficiency is it cell-adhesion mediated? Med Hypotheses, 1998, in press.